MacroGenics Statistics
Share Statistics
MacroGenics has 63.09M
shares outstanding. The number of shares has increased by 0.73%
in one year.
| Shares Outstanding | 63.09M |
| Shares Change (YoY) | 0.73% |
| Shares Change (QoQ) | 0.52% |
| Owned by Institutions (%) | 89.39% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 3 |
| FTD / Avg. Volume | n/a |
Short Selling Information
The latest short interest is 6.09M, so 9.66% of the outstanding
shares have been sold short.
| Short Interest | 6.09M |
| Short % of Shares Out | 9.66% |
| Short % of Float | 11.89% |
| Short Ratio (days to cover) | 14.38 |
Valuation Ratios
The PE ratio is -3.04 and the forward
PE ratio is -0.78.
MacroGenics's PEG ratio is
0.
| PE Ratio | -3.04 |
| Forward PE | -0.78 |
| PS Ratio | 1.37 |
| Forward PS | 0.7 |
| PB Ratio | 1.75 |
| P/FCF Ratio | -2.82 |
| PEG Ratio | 0 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for MacroGenics.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.92,
with a Debt / Equity ratio of 0.32.
| Current Ratio | 3.92 |
| Quick Ratio | 3.92 |
| Debt / Equity | 0.32 |
| Debt / EBITDA | -0.65 |
| Debt / FCF | -0.52 |
| Interest Coverage | -99.17 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $435,011.73 |
| Profits Per Employee | $-196,381.23 |
| Employee Count | 341 |
| Asset Turnover | 0.57 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 944K |
| Effective Tax Rate | -1.43% |
Stock Price Statistics
The stock price has increased by -65.37% in the
last 52 weeks. The beta is 1.63, so MacroGenics's
price volatility has been higher than the market average.
| Beta | 1.63 |
| 52-Week Price Change | -65.37% |
| 50-Day Moving Average | 1.46 |
| 200-Day Moving Average | 2.8 |
| Relative Strength Index (RSI) | 49.8 |
| Average Volume (20 Days) | 669,746 |
Income Statement
In the last 12 months, MacroGenics had revenue of 148.34M
and earned -66.97M
in profits. Earnings per share was -1.07.
| Revenue | 148.34M |
| Gross Profit | 136.04M |
| Operating Income | -110.58M |
| Net Income | -66.97M |
| EBITDA | -57.37M |
| EBIT | -64.91M |
| Earnings Per Share (EPS) | -1.07 |
Full Income StatementBalance Sheet
The company has 182.84M in cash and 37.46M in
debt, giving a net cash position of 145.38M.
| Cash & Cash Equivalents | 182.84M |
| Total Debt | 37.46M |
| Net Cash | 145.38M |
| Retained Earnings | -1.17B |
| Total Assets | 224.56M |
| Working Capital | 126.65M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -68.37M
and capital expenditures -3.71M, giving a free cash flow of -72.08M.
| Operating Cash Flow | -68.37M |
| Capital Expenditures | -3.71M |
| Free Cash Flow | -72.08M |
| FCF Per Share | -1.15 |
Full Cash Flow StatementMargins
Gross margin is 91.71%, with operating and profit margins of -74.54% and -45.14%.
| Gross Margin | 91.71% |
| Operating Margin | -74.54% |
| Pretax Margin | -44.51% |
| Profit Margin | -45.14% |
| EBITDA Margin | -38.67% |
| EBIT Margin | -74.54% |
| FCF Margin | -48.59% |
